Dongwoo Hyeon

Dongwoo Hyeon

Auto-generated profile, based on publicly available information

Dongwoo Hyeon

Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2024 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
HLHong Yeul Lee
Hong Yeul Lee
SCSoomin Chung
Soomin Chung
DHDongwoo Hyeon
Dongwoo Hyeon
HYHyun-Lim Yang
Hyun-Lim Yang
HLHyung-Chul Lee
Hyung-Chul Lee
HLHyeonhoon Lee
Hyeonhoon Lee
Delirium can result in undesirable outcomes including increased length of stays and mortality in patients admitted to the intensive care unit (ICU). Dexmedetomidine has emerged for delirium prevention in these patients; however, optimal dosing is challenging. A reinforcement learning-based Artificial Intelligence model for Delirium prevention (AID) is proposed to optimize dexmedetomidine dosing. The model was developed and internally validated using 2416 patients (2531 ICU admissions) and externally validated on 270 patients (274 ICU admissions). The estimated performance return of the AID policy was higher than that of the clinicians’ policy in both derivation (0.390 95% confidence interval [CI] 0.361 to 0.420 vs. −0.051 95% CI −0.077 to −0.025) and external validation (0.186 95% CI 0.139 to 0.236 vs. −0.436 95% CI −0.474 to −0.402) cohorts. Our finding indicates that AID might support clinicians’ decision-making regarding dexmedetomidine dosing to prevent delirium in ICU patients, but further off-policy evaluation is required.